Dermata Therapeutics, Inc.DRMAEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Dermata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm developing novel targeted therapies for dermatological diseases including acne, psoriasis and inflammatory skin disorders. It serves U.S. patients and healthcare providers, advancing pipeline candidates through trials to address unmet dermatological care needs.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 186.2K | flat | 2024-11-14 |
| Mitchell P. Kopin | 4.99% | 143.9K | — | 2023-06-01 |
Insider Transactions
Net 90d: +$1.3K · buys $1.3K / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-02-17 | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | Buy (open market) | 1.0K | $1.27 | $1.3K |
1–1 of 1